What Comes After the Cigarette: The Nicotine Ecosystem of 2040

The year is 2040. What does the nicotine landscape look like? The question is speculative—any forecast two decades out is uncertain—but it's not ungrounded. The trajectories that will shape the 2040 landscape are already visible: the decline of combustible cigarettes, the rise of non-combustible alternatives, the fragmentation of regulation, the concentration of the industry, the persistence of nicotine use in marginalized populations. Extrapolating these trajectories forward yields a picture of the nicotine ecosystem in 2040 that's neither utopian nor dystopian. It's a plausible future—contingent, revisable, and shaped by decisions being made now.

By 2040, combustible cigarettes will be largely eliminated from high-income countries. Smoking prevalence in Western Europe, North America, and Australasia will be below 5%—the 'smoke-free' threshold—in most jurisdictions. Cigarettes will still be available but marginalized: sold in limited retail outlets, heavily taxed, and used primarily by the most dependent, most marginalized smokers for whom the transition to non-combustible products has not succeeded. The cigarette market in high-income countries will be a residual market—small, stigmatized, and declining—analogous to the market for chewing tobacco or other legacy nicotine products. The elimination of cigarettes from high-income countries will be a public health triumph. The persistence of a residual smoking population among the most marginalized will be a reminder that transitions leave people behind.

In low- and middle-income countries, the picture will be more mixed. Some upper-middle-income countries (Brazil, Thailand, South Africa) will have followed the high-income trajectory, with smoking declining and non-combustible alternatives increasingly available. Lower-income countries, particularly in sub-Saharan Africa and parts of South Asia, will still have significant smoking rates. The tobacco industry's dual strategy—promoting 'smoke-free' products in high-income markets while maintaining cigarette sales in LMICs—will have produced a bifurcated global nicotine landscape. The health equity gap will be stark: the populations that can least afford the healthcare costs of smoking-related disease will be the ones still experiencing it at the highest rates.

The nicotine product landscape in 2040 will be dominated by oral products—nicotine pouches and their successors—with vaping as a secondary category and heated tobacco as a regional niche. The trajectory from inhalation to oral delivery, already visible in the shift from vaping to pouches among young adults, will have continued. The products will be more sophisticated than today's pouches: precisely dosed, pharmacokinetically optimized, with formulations that are tailored to individual metabolism and preference. The distinction between pharmaceutical NRT and consumer nicotine products will have blurred as both converge on similar delivery technologies and safety profiles. The nicotine market will resemble the caffeine market: a range of products at similar risk levels, differentiated primarily by format and brand rather than by harm.

The regulatory landscape will have evolved toward greater coherence, though not uniformity. A risk-proportionate framework—products regulated based on their toxicological profile, with combustible products restricted most heavily and non-combustible products regulated as consumer goods with product standards—will be the dominant model in high-income countries. The WHO FCTC will have evolved (belatedly and incompletely) to accommodate harm reduction within its framework. The global regulatory architecture will be more coordinated, with mutual recognition of product authorizations and aligned product standards across major markets. The fragmentation that characterized the 2020s will have given way to convergence around the risk-proportionate model—driven not by institutional conversion but by the accumulating epidemiological evidence from the countries that adopted it early.

The cultural position of nicotine in 2040 will be fundamentally different from its position in the 20th century. Nicotine use will be normalized—not in the sense of being universally accepted, but in the sense of being treated similarly to caffeine: a legal, regulated psychoactive substance used by a significant minority of the population, with acknowledged risks (addiction, cardiovascular effects) and acknowledged benefits (cognitive enhancement, stress management). The moral charge that nicotine carried in the 20th century—the association with deadly smoke, industry deception, and stigmatized addiction—will have dissipated as combustible tobacco has been largely eliminated. Nicotine will be understood as a substance that carries risks and benefits, like any psychoactive compound, and that can be used in ways that are more or less harmful. The nicotine user of 2040 will be no more stigmatized than the coffee drinker of today.

The public health outcome in 2040 will be dramatically improved relative to the baseline of the early 21st century. Global smoking-related mortality will have peaked and begun to decline—the lagged effect of reduced smoking initiation and increased cessation will finally be visible in the mortality data. The annual tobacco death toll, which stood at 7 million in the 2020s, will be declining toward 3–4 million in the 2040s—still enormous, still concentrated among the poor, but no longer rising. The nicotine transition will have saved tens of millions of lives compared to a counterfactual of continued cigarette dominance. It will not have eliminated nicotine-related harm. Nicotine addiction will persist. The long-term health effects of decades of vaping and pouch use will have become clearer. But the scale of suffering will have been transformed. The nicotine landscape of 2040 will not be a utopia. It will be a world where the deadliest delivery system ever invented has been largely replaced by alternatives that are dramatically safer—and where the preventable death that defined the early 21st century has been substantially reduced.